| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/PM/PNX321 |
| P698 | PubMed publication ID | 29309700 |
| P50 | author | Stephan A. Schug | Q37830606 |
| P2093 | author name string | Janakan Krishnarajah | |
| Stephen Chin Beng Lim | |||
| P2860 | cites work | Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology | Q28080140 |
| Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naı̈ve healthy male volunteers under a naltrexone block | Q33389907 | ||
| The systemic availability of buprenorphine administered by nasal spray | Q34043412 | ||
| Buprenorphine: a review of its pharmacological properties and therapeutic efficacy | Q34190621 | ||
| Opioid rotation in clinical practice | Q34305249 | ||
| Bioavailability of sublingual buprenorphine | Q34417674 | ||
| Buccal and sublingual vaccine delivery | Q34423731 | ||
| Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis | Q34450083 | ||
| Buprenorphine induces ceiling in respiratory depression but not in analgesia | Q34651926 | ||
| Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine | Q34787766 | ||
| Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers | Q35191060 | ||
| Buprenorphine: considerations for pain management | Q36076433 | ||
| Drug delivery via the mucous membranes of the oral cavity | Q36272912 | ||
| Current knowledge of buprenorphine and its unique pharmacological profile | Q37759279 | ||
| Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature | Q37960128 | ||
| Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain | Q38027251 | ||
| Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment | Q38178739 | ||
| Multidose/Observational, Comparative Clinical Analgetic Evaluation of Buprenorphine | Q39567253 | ||
| Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor-mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects | Q40125202 | ||
| Hypogonadism in men receiving methadone and buprenorphine maintenance treatment | Q40158847 | ||
| Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence | Q44346997 | ||
| Hypogonadism in men consuming sustained-action oral opioids | Q44658639 | ||
| Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality | Q44841293 | ||
| QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial | Q46856827 | ||
| Double-blind, multiple-dose comparison of buprenorphine and morphine in postoperative pain. | Q51872039 | ||
| Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers. | Q53200751 | ||
| P921 | main subject | pharmacokinetics | Q323936 |
| P577 | publication date | 2018-01-03 | |
| P1433 | published in | Pain Medicine | Q15746562 |
| P1476 | title | The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine |
| Q92266621 | Feasibility and efficacy of sublingual buprenorphine tablets in managing acute postoperative pain after elective breast cancer surgeries: A series of 10 cases | cites work | P2860 |
Search more.